Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.
Citation: LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.

Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly

  • Received Date: 2003-08-29
  • Objective To evaluate the economic effectiveness of 3 therapeutic schemes for lower respiratory tract infection in the elderly. Methods Three schemes of the treatment of lower respiratory tract infection in the elderly from literatrure cefoperazone/sulbactam(A), imipenem/cilastatin(B), ceftazidime(C) were selected. Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. Results According to the evaluation by cost-effectiveness analysis, C was the best scheme. Conclusion The cost-effectiveness analysis is very important in optimizing therapeutic scheme, guiding rational drug use and increasing economic effectiveness.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2242) PDF downloads(281) Cited by()

Related
Proportional views

Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly

Abstract: Objective To evaluate the economic effectiveness of 3 therapeutic schemes for lower respiratory tract infection in the elderly. Methods Three schemes of the treatment of lower respiratory tract infection in the elderly from literatrure cefoperazone/sulbactam(A), imipenem/cilastatin(B), ceftazidime(C) were selected. Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. Results According to the evaluation by cost-effectiveness analysis, C was the best scheme. Conclusion The cost-effectiveness analysis is very important in optimizing therapeutic scheme, guiding rational drug use and increasing economic effectiveness.

LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.
Citation: LAO Guo-qin, TANG Zhi-hua, XU Wen-yu. Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly[J]. Journal of Pharmaceutical Practice and Service, 2004, (2): 106-107.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return